Amarin Corp Plc (AMRN)

[Whalatane]

I assume U know he engineered the sale of MDCO … whose main asset was its PCSK9 it developed to lower LDL cholesterol… to NVS
NVS already had a large EU cardio presence / sales force etc in place and thus could generate cash flow from selling the PCSK9 …. far faster then MDCO could starting from scratch.

Same approach will apply with AMRN once the reimbursement decisions are made re which population will be covered

Then I expect Denner to try and force a sale of EU market to NVS .
Doubt NVS is interested in all of AMRN for the reason Rose noted … to messy

Kiwi